Richman, Long, Lindsay, et al.
Diagnostic excellence requires balancing early detection with overuse, cost, and potential harms. This serial cross-sectional SEER-Medicare study examined breast cancer screening among women aged 67 years and older from 2009–2019. Screening patterns, costs, and estimated value varied by age, modality, and frequency, and ineffective screening costs accounted for over 50% of spending and over $1 billion. The results highlight the importance of aligning screening intensity with expected benefit.